# Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

> **NCT00876616** · NA · COMPLETED · sponsor: **Zhi-Hong Liu, M.D.** · enrollment: 362 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Tacrolimus+Mycophenolate mofetil
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00876616
- **Lead sponsor:** Zhi-Hong Liu, M.D.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-05
- **Final completion:** 2012-02
- **Target enrollment:** 362 (ACTUAL)
- **Last updated:** 2013-08-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876616, "Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00876616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*